318 related articles for article (PubMed ID: 17495527)
1. Localized treatment with a novel FDA-approved proteasome inhibitor blocks the degradation of dystrophin and dystrophin-associated proteins in mdx mice.
Bonuccelli G; Sotgia F; Capozza F; Gazzerro E; Minetti C; Lisanti MP
Cell Cycle; 2007 May; 6(10):1242-8. PubMed ID: 17495527
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.
Gazzerro E; Assereto S; Bonetto A; Sotgia F; Scarfì S; Pistorio A; Bonuccelli G; Cilli M; Bruno C; Zara F; Lisanti MP; Minetti C
Am J Pathol; 2010 Apr; 176(4):1863-77. PubMed ID: 20304949
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins.
Bonuccelli G; Sotgia F; Schubert W; Park DS; Frank PG; Woodman SE; Insabato L; Cammer M; Minetti C; Lisanti MP
Am J Pathol; 2003 Oct; 163(4):1663-75. PubMed ID: 14507673
[TBL] [Abstract][Full Text] [Related]
4. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
Araujo KP; Bonuccelli G; Duarte CN; Gaiad TP; Moreira DF; Feder D; Belizario JE; Miglino MA; Lisanti MP; Ambrosio CE
PLoS One; 2013; 8(4):e61367. PubMed ID: 23579193
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
8. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
9. Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.
Micheletto MLJ; Hermes TA; Bertassoli BM; Petri G; Perez MM; Fonseca FLA; Carvalho AAS; Feder D
Int J Exp Pathol; 2021 Feb; 102(1):11-21. PubMed ID: 33296126
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
Kumar A; Bhatnagar S; Kumar A
Am J Pathol; 2010 Jul; 177(1):248-60. PubMed ID: 20472898
[TBL] [Abstract][Full Text] [Related]
11. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
Siemionow M; Langa P; Harasymczuk M; Cwykiel J; Sielewicz M; Smieszek J; Heydemann A
Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment.
Assereto S; Stringara S; Sotgia F; Bonuccelli G; Broccolini A; Pedemonte M; Traverso M; Biancheri R; Zara F; Bruno C; Lisanti MP; Minetti C
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C577-82. PubMed ID: 16192300
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
Oliveira-Santos A; Dagda M; Burkin DJ
Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045
[TBL] [Abstract][Full Text] [Related]
16. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B
Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847
[TBL] [Abstract][Full Text] [Related]
17. Brain function in Duchenne muscular dystrophy.
Anderson JL; Head SI; Rae C; Morley JW
Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
[TBL] [Abstract][Full Text] [Related]
18. Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.
Cea LA; Puebla C; Cisterna BA; Escamilla R; Vargas AA; Frank M; Martínez-Montero P; Prior C; Molano J; Esteban-Rodríguez I; Pascual I; Gallano P; Lorenzo G; Pian H; Barrio LC; Willecke K; Sáez JC
Cell Mol Life Sci; 2016 Jul; 73(13):2583-99. PubMed ID: 26803842
[TBL] [Abstract][Full Text] [Related]
19. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.
Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I
J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326
[TBL] [Abstract][Full Text] [Related]
20. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
